Delivery Order SPE2DR25D2216-SPE2DR26F7TX6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,536.80 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The contract involves no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $9,191.62 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, which is expected to be completed by November 7, 2025, was awarded competitively with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a $11,834.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside competitive award will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $8,079.02 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on May 30, 2025, with completion scheduled for June 2, 2025. This non-set-aside, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a $3,521.86 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-set-aside, firm fixed-price contract is scheduled for completion by August 14, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $1,994.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This competitive award, with no set-aside designation, is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,550.08 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on November 13, 2025, with completion scheduled for November 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,349.70 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,060.15 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. The delivery order, which is not set-aside, represents performance to be completed by November 18, 2025, at the contractor's corporate office location in Conshohocken, Pennsylvania. This competitively awarded order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- SPE2DR25D2216Indefinite Delivery Contract
- SPE2DR25D2216-SPE2DR26F7TX6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,984.96 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors on November 17, 2025, with completion expected by November 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and runs through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare systems through its comprehensive pharmaceutical and medical supply offerings. This delivery order for Mounjaro, a diabetes medication, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare programs. The underlying SPE2DX contract represents a global pharmaceutical prime vendor vehicle enabling AmerisourceBergen to supply specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 11/17/25 |